TNF and Sjogren syndrome: Clinical efficacy of abatacept has been reported in patients with active RA, including those with an inadequate response to MTX or TNF inhibitors [41], in early type 1 diabetes mellitus, and more recently, in primary Sjögren’s syndrome [21, 42].